Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 178 of 6351
-
Blood test may predict which lung cancer drug works best
Disease control CompletedUsing a laboratory test (VeriStrat), patients with relapsed squamous cell lung cancer are assigned to two strata, VSG (VeriStrat Good) and VSP (VeriStrat Poor). They are then randomized between an EGFR-TK inhibitor (erlotinib) and chemotherapy (Docetaxel). It is hypothesized tha…
Phase 3 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Can brain stimulation awaken the mind after a coma?
Disease control CompletedChronic post-coma consciousness impairment is a severe handicap. Preliminary studies suggest that deep brain stimulation of the thalamic-tegmental reticular system could improve consciousness disorders, and facilitate the emergence of conscious behavior. The aim of this protocol …
Sponsor: University Hospital, Clermont-Ferrand • Aim: Disease control
Last updated Aug 07, 2026 00:00 UTC
-
Broader pneumonia shield: new vaccine tested in children
Vaccine CompletedThis open-label, multicenter study is designed to evaluate the safety, tolerability and immunogenicity of 13-valent pneumococcal conjugate vaccine in healthy children aged more than 15 months up to less than 18 years.
Phase 3 • Sponsor: Pfizer • Aim: Vaccine
Last updated Jul 23, 2026 00:00 UTC
-
New hope for breast cancer survivors: letrozole extends remission
Disease control CompletedRATIONALE: Estrogen can stimulate the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by reducing the production of estrogen. PURPOSE: This randomized phase III trial is studying letrozole to see how well it works in treating women with bre…
Phase 3 • Sponsor: NCIC Clinical Trials Group • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
Can a more intense radiation schedule outperform Chemo-Radiation for head and neck cancer?
Disease control CompletedAltered fractionated radiotherapy and concomitant radio-chemotherapy have been shown to be two possibilities for improving efficacy of radiotherapy in locally advanced head and neck carcinomas. In this multicentric study, we tested the hypothesis that accelerated radiotherapy cou…
Phase 2/3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Aug 21, 2026 00:00 UTC
-
New hope for rare epilepsy: fenfluramine made available for dravet patients
Disease control ApprovedThe purpose of this research study is to (1) provide access to fenfluramine for patients with intractable epilepsy associated with Dravet syndrome, and (2) evaluate the safety of fenfluramine.
Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Experimental drug targets smallpox and monkeypox after exposure
Disease control Expanded accessThe purpose of this clinical protocol is to treat individuals with Tecovirimat after exposure to orthopox viruses.
Sponsor: U.S. Army Medical Research and Development Command • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Can a shorter radiation course beat anal cancer?
Disease control Not yet recruitingThis phase 2 single-arm study will evaluate whether a shortened course of mildly hypofractionated radiation therapy given with standard concurrent chemotherapy (mitomycin C and capecitabine) can provide acceptable tumor control in patients with high-risk non-metastatic anal squam…
Phase 2 • Sponsor: University of Vermont Medical Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Zapping the brain to preserve memory — a precision approach puts it to the test
Symptom relief Not yet recruitingThis project optimizes high-resolution tACS to improve memory in healthy older adults, advancing drug-free approaches for ADRD. We test stimulation schedules and develop an adaptive, brain-guided tACS system to strengthen memory-supporting networks.
Sponsor: Boston University Charles River Campus • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Can monthly malaria pills sharpen Children's minds?
Prevention Not yet recruitingMalaria remains a major cause of illness among school-aged children in sub-Saharan Africa, many of whom carry asymptomatic Plasmodium falciparum infections that may contribute to anemia, inflammation, school absenteeism, and impaired cognitive performance. Intermittent preventive…
Phase 3 • Sponsor: Indiana University • Aim: Prevention
Last updated Sep 03, 2026 00:00 UTC
-
Can a new infusion slow a heart disease caused by protein clumps?
Disease control Not yet recruitingThe purpose of Study ALXN2220-ATTRCM-302 is to evaluate the long-term safety, tolerability and efficacy of ALXN2220 in adult participants with ATTR-CM treated with ALXN2220 in addition to SoC who have completed Study ALXN2220-ATTRCM-301.
Phase 3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Aug 29, 2026 00:00 UTC
-
Testosterone may rebuild strength after spinal cord injury — trial puts it to the test
Disease control Not yet recruitingSpinal cord injury (SCI) results in lower limb muscle loss, bone loss, and high fat mass that impede the recovery of physical function, increase bone fracture risk, and worsen health and quality of life. These deficits result from reduced activity after SCI and may be worsened by…
Phase 2/3 • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Aug 06, 2026 00:00 UTC
-
Could a common blood pressure pill recharge brain cells in Alzheimer's?
Disease control Not yet recruitingThe TAME-AD trial will be a randomized, double-blind, placebo-controlled Phase IIa clinical trial to evaluate the metabolic target engagement of terazosin for the treatment of Alzheimer's disease.
Phase 2 • Sponsor: Qiang Zhang • Aim: Disease control
Last updated Sep 03, 2026 00:00 UTC
-
Can a drug that blocks HER proteins re-sensitize resistant breast cancer to hormone therapy?
Disease control Not yet recruitingThe goal of this clinical trial is to learn if neratinib, an FDA-approved oral pan-HER2/3/4 inhibitor, improves disease control for participants with metastatic endocrine-resistant ER+/HER2-negative breast cancer. Neratinib is already approved for the treatment of HER2-postive br…
Phase 2 • Sponsor: University of California, San Diego • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Engineered immune cells take on Hard-to-Treat sarcomas
Disease control Not yet recruitingThe aim of this clinical trial is to assess the feasibility, safety and efficacy of CAR T cells immunotherapy in patients who have sarcoma that is relapsed or late staged. Another goal of the study is to assess the safety and efficacy of the therapy that combines CAR T cells and …
Phase 1/2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Could a preventive ablation during flutter treatment ward off future heart trouble?
Disease control Not yet recruitingPulmonary vein isolation (PVI) via catheter ablation has been successfully employed for years to treat symptomatic atrial fibrillation (AF). Moreover, PVI has not been used as a prophylactic intervention even in groups known to be high-risk for the future development of AF. Preli…
Sponsor: University of Rochester • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a DNA repair gene flaw make melanoma vulnerable to chemotherapy?
Disease control Not yet recruitingBAP1, or BRCA1-associated protein 1, is a gene involved in DNA repair via homologous recombination and is considered a tumor suppressor gene. It is lost or inactivated in a large number of tumors, and the presence of germline BAP1 mutations is associated with a syndrome of tumor …
Phase 2 • Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Menopause heart risk targeted by tailored exercise and diet programs
Prevention Not yet recruitingCardiovascular disease is the leading cause of death in women, yet risk is systematically underestimated and preventive interventions are often initiated too late. Women are disproportionately affected by obesity, diabetes, and smoking, but they also derive greater cardioprotecti…
Sponsor: Ludwig Boltzmann Institute for Cardiovascular Research • Aim: Prevention
Last updated Jul 23, 2026 00:00 UTC
-
A softer path for kidney disease: could palliative care ease the burden?
Symptom relief Not yet recruitingThe purpose of study is to investigate whether adding palliative care to usual chronic kidney disease (CKD) care improves symptoms and quality of life for people with CKD. The primary objectives are to 1) determine efficacy of Kidney Palliative Care (KPC) integrated with CKD care…
Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Aug 05, 2026 00:00 UTC
-
New radiation method may make stem cell transplants safer for older leukemia patients
Disease control Recruiting nowThis phase II trial tests the effect of total marrow and lymphoid irradiation (TMLI) in combination with fludarabine and melphalan as conditioning regimen in older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome that has not responded to previous treatm…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC